Net Income Summary of Formosa Laboratories, Inc.

Formosa Laboratories, Inc.'s latest annual net income in 2023 was 126.24 Million TWD , down -41.77% from previous year.
Formosa Laboratories, Inc.'s latest quarterly net income in 2024 Q2 was 283.92 Million TWD , up 387.78% from previous quarter.
Formosa Laboratories, Inc. reported an annual net income of 216.81 Million TWD in 2022, down -82.64% from previous year.
Formosa Laboratories, Inc. reported an annual net income of 1.24 Billion TWD in 2021, up 212.25% from previous year.
Formosa Laboratories, Inc. reported a quarterly net income of 283.92 Million TWD for 2024 Q2, up 387.78% from previous quarter.
Formosa Laboratories, Inc. reported a quarterly net income of 126.24 Million TWD for 2023 FY, down -41.77% from previous quarter.

Annual Net Income Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Net Income of Formosa Laboratories, Inc. (2023 - 2009)

Year	Net Income	Net Income Growth
2023	126.24 Million TWD	-41.77%
2022	216.81 Million TWD	-82.64%
2021	1.24 Billion TWD	212.25%
2020	400.03 Million TWD	1074.22%
2019	-41.06 Million TWD	-123.22%
2018	176.82 Million TWD	-25.91%
2017	238.64 Million TWD	-50.64%
2016	483.44 Million TWD	71.2%
2015	282.39 Million TWD	7.58%
2014	262.49 Million TWD	478.23%
2013	-69.4 Million TWD	-1487.19%
2012	5 Million TWD	-97.83%
2011	231.06 Million TWD	-6.31%
2010	246.62 Million TWD	0.0%
2009	- TWD	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-98.66 Million TWD	-154.04%
2024 Q2	283.92 Million TWD	387.78%
2023 FY	126.24 Million TWD	-41.77%
2023 Q4	182.58 Million TWD	259.39%
2023 Q3	-114.55 Million TWD	-237.39%
2023 Q2	83.37 Million TWD	221.59%
2023 Q1	-68.57 Million TWD	-121.02%
2022 Q3	492.08 Million TWD	1089.45%
2022 Q1	-454.25 Million TWD	-156.96%
2022 FY	216.81 Million TWD	-82.64%
2022 Q4	326.16 Million TWD	-33.72%
2022 Q2	-49.73 Million TWD	89.05%
2021 Q3	-384.56 Million TWD	-151.64%
2021 Q2	744.62 Million TWD	-30.14%
2021 FY	1.24 Billion TWD	212.25%
2021 Q1	1.06 Billion TWD	900.44%
2021 Q4	-176.78 Million TWD	54.03%
2020 Q2	534.17 Million TWD	624.32%
2020 Q3	100.89 Million TWD	-81.11%
2020 FY	400.03 Million TWD	1074.22%
2020 Q1	-101.88 Million TWD	-38.88%
2020 Q4	-133.15 Million TWD	-231.97%
2019 Q2	-118.94 Million TWD	-470.06%
2019 Q1	32.14 Million TWD	-68.75%
2019 Q4	-73.35 Million TWD	-142.7%
2019 Q3	171.78 Million TWD	244.43%
2019 FY	-41.06 Million TWD	-123.22%
2018 Q1	171.06 Million TWD	497.81%
2018 Q3	-124.34 Million TWD	-556.08%
2018 Q4	102.84 Million TWD	182.71%
2018 FY	176.82 Million TWD	-25.91%
2018 Q2	27.26 Million TWD	-84.06%
2017 Q3	38.96 Million TWD	-67.44%
2017 Q2	119.65 Million TWD	132.77%
2017 Q1	51.4 Million TWD	-62.48%
2017 FY	238.64 Million TWD	-50.64%
2017 Q4	28.61 Million TWD	-26.56%
2016 Q2	145.96 Million TWD	40.1%
2016 FY	483.44 Million TWD	71.2%
2016 Q3	96.27 Million TWD	-34.04%
2016 Q1	104.18 Million TWD	-5.71%
2016 Q4	137.01 Million TWD	42.32%
2015 Q4	110.49 Million TWD	-2.83%
2015 Q2	16.62 Million TWD	-59.99%
2015 Q1	41.56 Million TWD	-29.13%
2015 Q3	113.71 Million TWD	583.81%
2015 FY	282.39 Million TWD	7.58%
2014 Q1	55.8 Million TWD	16.27%
2014 FY	262.49 Million TWD	478.23%
2014 Q4	58.64 Million TWD	-34.32%
2014 Q3	89.28 Million TWD	51.96%
2014 Q2	58.75 Million TWD	5.28%
2013 Q4	47.99 Million TWD	8.0%
2013 Q1	-163.96 Million TWD	-652.53%
2013 Q2	2.12 Million TWD	101.29%
2013 FY	-69.4 Million TWD	-1487.19%
2013 Q3	44.44 Million TWD	1996.37%
2012 Q2	23.02 Million TWD	-1.93%
2012 Q1	23.47 Million TWD	-56.28%
2012 Q3	-20.32 Million TWD	-188.25%
2012 Q4	-21.78 Million TWD	-7.22%
2012 FY	5 Million TWD	-97.83%
2011 Q1	67.31 Million TWD	-72.7%
2011 Q4	53.69 Million TWD	-16.48%
2011 Q2	45.75 Million TWD	-32.03%
2011 Q3	64.29 Million TWD	40.52%
2011 FY	231.06 Million TWD	-6.31%
2010 Q4	246.62 Million TWD	0.0%
2010 Q1	- TWD	0.0%
2010 Q2	- TWD	0.0%
2010 FY	246.62 Million TWD	0.0%
2010 Q3	- TWD	0.0%
2009 FY	- TWD	0.0%

Peer Net Income Comparison of Formosa Laboratories, Inc.

Name	Net Income	Net Income Difference
Grape King Bio Ltd	1.45 Billion TWD	91.31%
Standard Chem & Pharm CO., LTD.	834.88 Million TWD	84.879%
Maywufa Company Ltd.	169.09 Million TWD	25.343%
ScinoPharm Taiwan, Ltd.	287.05 Million TWD	56.021%
Lotus Pharmaceutical Co., Ltd.	4.1 Billion TWD	96.925%
LIWANLI Innovation Co., Ltd.	5.1 Million TWD	-2373.898%
YungShin Global Holding Corporation	827.3 Million TWD	84.74%
PhytoHealth Corporation	-47.11 Million TWD	367.935%
SCI Pharmtech, Inc.	294.72 Million TWD	57.165%
PharmaEssentia Corporation	-623.83 Million TWD	120.237%
Bora Pharmaceuticals Co., LTD.	3.03 Billion TWD	95.834%

Global Stocks Search

Formosa Laboratories, Inc. (4746.TW)

Net Income Summary of Formosa Laboratories, Inc.

Annual Net Income Chart of Formosa Laboratories, Inc. (2023 - 2009)

Historical Annual Net Income of Formosa Laboratories, Inc. (2023 - 2009)

Peer Net Income Comparison of Formosa Laboratories, Inc.